Inventor
Kristian T. Poulsen
Inventor
San Francisco, CA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
10,597,448Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptide202010,329,343Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide201910,323,085Methods of treating fibromyalgia20199,890,211'Antagonist antibodies directed against calcitonin gene-related peptide'20189,890,210'Antagonist antibodies directed against calcitonin gene-related peptide'20189,884,908'Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide'20189,884,907'Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide'20189,365,648'Methods of using anti-CGRP antagonist antibodies'20169,346,881'Antagonist antibodies directed against calcitonin gene-related peptide and methods using same'20169,340,614'Antagonist antibodies directed against calcitonin gene-related peptide and methods using same'20169,328,168'Methods of using anti-CGRP antagonist antibodies'20169,328,167'Methods of treating chronic pain'20169,279,018'Antagonist antibodies directed against calcitonin gene-related peptide and methods using same'20169,266,951'Antagonist antibodies directed against calcitonin gene-related peptide and methods using same'20169,115,194'Antagonist antibodies directed against calcitonin gene-related peptide and methods using same'20158,734,802'Methods of treating vasomotor symptoms using antibodies'20148,623,366'Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide'20148,597,649'Antagonist antibodies directed against calcitonin gene-related peptide and methods using same'20138,586,045'Methods of using anti-CGRP antagonist antibodies'20138,298,536'Methods of treating inflammatory pain'20128,293,239'Methods of treating chronic pain'20128,007,794'Antagonist antibodies directed against calcitonin gene-related peptide and methods using same'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2020Based in San Francisco, CA, US· patent location history
2012–2014Patents assigned to ZELLER JOERG (4)· patent assignee history
2012–2014Patents assigned to POULSEN KRISTIAN TODD (3)· patent assignee history
2012–2014Patents assigned to SHELTON DAVID LOUIS (3)· patent assignee history
2012Based in South San Francisco, CA, US· patent location history
2013–2016Patents assigned to LABRYS BIOLOG INC (11)· patent assignee history
2018–2020Patents assigned to TEVA PHARMACEUTICALS INT GMBH (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LABRYS BIOLOG INC | 11 | 2013–2016 |
| TEVA PHARMACEUTICALS INT GMBH | 7 | 2018–2020 |
| ZELLER JOERG | 4 | 2012–2014 |
| POULSEN KRISTIAN TODDself | 3 | 2012–2014 |
| SHELTON DAVID LOUIS | 3 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 21 | 2011–2020 |
| South San Francisco, California, US | 1 | 2012 |